| 2020 | Stentys S.A. Reports Earnings Results for the Half Year Ended June 30, 2020 | CI |
| 2020 | STENTYS : Financial Information for the First Quarter Of 2020 | BU |
| 2020 | STENTYS S.A. Announces Revenue Results for the First Quarter Of 2020 | CI |
| 2020 | STENTYS : Financial Information for the First Quarter of 2020 | PU |
| 2020 | STENTYS : 2019 Annual Results | PU |
| 2019 | STENTYS : Convening of another Combined General Meeting on November 14, 2019 | PU |
| 2019 | STENTYS : 2019 half-year results | PU |
| 2019 | Stentys Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2019 | CI |
| 2019 | STENTYS : Financial Information for the Third Quarter of 2019 | PU |
| 2019 | STENTYS : Financial Information for the First Half of 2019 | PU |
| 2019 | STENTYS : Convening of another Combined General Meeting on June 25, 2019 | PU |
| 2019 | STENTYS : Financial Information for the First Quarter of 2019 | PU |
| 2019 | Stentys S.A. Announces Revenue Results for the First Quarter 2019 | CI |
| 2019 | STENTYS : 2018 Annual results | PU |
| 2019 | Stentys Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2.. | CI |
| 2019 | 2018 REVENUES : exceeding €10 million on a pro forma basis | PU |
| 2019 | Stentys S.A. Announces Audited Revenue Results for the Fourth Quarter and Full Year End.. | CI |
| 2018 | STENTYS : Financial Information for the Third Quarter of 2018 | PU |
| 2018 | STENTYS S.A. Announces Consolidated Revenue Results for the Third Quarter and Nine Mont.. | CI |
| 2018 | STENTYS : 2018 half-year results | PU |
| 2018 | STENTYS Announces Earnings Results for the Six Months Ended June 30, 2018 | CI |
| 2018 | STENTYS S.A. Announces Unaudited Consolidated Revenue Results for the Second Quarter an.. | CI |
| 2018 | STENTYS : Report on the General Meeting of June 4, 2018 | PU |
| 2018 | STENTYS : Convening of another Combined General Meeting on June 4, 2018 | PU |
| 2018 | STENTYS S.A. completed the acquisition of Minvasys. | CI |
| 2018 | STENTYS S.A. Reports Revenue Results for the First Quarter Ended March 31, 2018 | CI |
| 2018 | STENTYS S.A. Announces Audited Consolidated Earnings Results for the Year Ended Decembe.. | CI |
| 2018 | STENTYS : RIGHTS ISSUE: 13 new shares @ 1.42 EUR for 28 existing shares | FA |
| 2018 | STENTYS : announces plans to acquire MINVASYS | PU |
| 2018 | STENTYS S.A. entered into an exclusive negotiations agreement to acquire Minvasys for €.. | CI |
| 2018 | STENTYS S.A. Announces Unaudited Revenue Results for the Fourth Quarter and Full Year o.. | CI |
| 2017 | STENTYS S.A. Announces the Pre-Commercialization of SERPENTIS, Its New Latest-Generatio.. | CI |
| 2017 | 12 OCTOBER 2017 : Revenues for the Third Quarter of 2017 | PU |
| 2017 | STENTYS S.A. Announces Unaudited Revenue Results for the Third Quarter and First Nine M.. | CI |
| 2017 | STENTYS S.A. Announces Earnings Results for the Six Months Ended June 30, 2017 | CI |
| 2017 | 02 OCTOBER 2017 : 2017 half-year results | PU |
| 2017 | 27 JULY 2017 : STENTYS Completes Enrollment of the TRUNC Study | PU |
| 2017 | 12 JULY 2017 : Revenues of €1.7 million in the second quarter of 2017 | PU |
| 2017 | STENTYS S.A. Announces Unaudited Revenue Results for the Second Quarter and First Half .. | CI |
| 2017 | 22 JUNE 2017 : Report on the Combined Shareholders' Meeting of June 22, 2017 | PU |
| 2017 | 24 MAY 2017 : Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3.. | PU |
| 2017 | STENTYS S.A. cancelled the transaction announced on May 14, 2014 | CI |
| 2017 | STENTYS S.A. Announces Revenue Results for the First Quarter Ended March 31, 2017 | CI |
| 2017 | 03 APRIL 2017 : STENTYS is strengthening its Board by co-opting two new independent member.. | PU |
| 2017 | STENTYS S.A. Announces Executive Changes | CI |
| 2017 | STENTYS S.A. Reports Earnings Results for the Year Ended December 31, 2016 | CI |
| 2017 | 12 JANUARY 2017 : 2016 Annual Revenues up 20% at €7.3 Million | PU |
| 2017 | STENTYS Reports Revenue Results for the Fourth Quarter and Full Year of 2016 | CI |
| 2016 | 12 OCTOBER 2016 : STENTYS Reports 26% Year-over-Year Growth in Nine-Month 2016 Revenues | PU |
| 2016 | STENTYS Announces Revenue Results for the Third Quarter and Nine Months Ended September.. | CI |
| 2016 | 15 SEPTEMBER 2016 : 2016 First-Half Results | PU |
| 2016 | STENTYS Announces Consolidated Earnings Results for the Half-Year Ended June 30, 2016 | CI |
| 2016 | STENTYS Enrolls First Patient in Left Main Clinical Trial | CI |
| 2016 | 12 JULY 2016 : STENTYS: 41% Increase in Revenues in the Second Quarter of 2016 | PU |
| 2016 | STENTYS Reports Revenue Results for the Second Quarter and Six Months Ended June 30, 20.. | CI |
| 2016 | 04 JULY 2016 : STENTYS: Appointment of Cardiovascular Device Veteran as New CEO | PU |
| 2016 | STENTYS Appoints Christophe Lottin as CEO | CI |
| 2016 | 04 JULY 2016 : STENTYS: Appointment of Cardiolovascular Device Veteran as New CEO | PU |
| 2016 | 08 JUNE 2016 : STENTYS Announces CE Marking of its longest Xposition stent | PU |
| 2016 | 12 MAY 2016 : Convening of another Annual General Meeting on June 16, 2016 | PU |
| 2016 | STENTYS : Announces the CE Marking of the Self-Apposing Stent for Left Main Coronary Arter.. | PU |
| 2016 | STENTYS Announces the CE Marking of the Self-Apposing Stent for Left Main Coronary Arte.. | CI |
| 2016 | STENTYS : Reports 2015 Annual Results (16 March 2016) | PU |
| 2016 | STENTYS Reports Earnings Results for the Year Ended December 31, 2015 | CI |
| 2016 | STENTYS : 28 February 2016: Results of Self-Apposing Sirolimus-Eluting Stent Trial Publish.. | PU |
| 2016 | STENTYS : 29 February 2016: Results of Self-Apposing Sirolimus-Eluting Stent Trial Publish.. | PU |
| 2016 | STENTYS : RIGHTS ISSUE: 6 new shares @ 2.25 EUR for 13 existing shares | FA |
| 2016 | STENTYS : 08 February 2016: Launch of the Commercialization of the first Self-Expanding Dr.. | PU |
| 2016 | STENTYS : 28 January 2016: First Intervention with the Self-Apposing Drug-Eluting Stent fo.. | PU |
| 2016 | STENTYS : Reports 81% Year-over-Year Growth in Fourth-Quarter 2015 Revenues (13 January 20.. | PU |
| 2016 | STENTYS Announces Revenues Results for the Fourth Quarter and Full Year 2015 | CI |
| 2015 | STENTYS : 22 December 2015: 2016 Financial Agenda | PU |
| 2015 | STENTYS : 09 December 2015: Enrollment Completion of MiStent Randomized Trial against Xien.. | PU |
| 2015 | STENTYS : Reports 84% Growth in Third-Quarter 2015 Revenues (15 October 2015) | PU |
| 2015 | STENTYS : Sirolimus-Eluting Stent Confirms Best-in-Class Performance at 3 Years (12 Octobe.. | PU |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
